Abraham Ceesay
Chief Executive Officer, Director · Rapport Therapeutics, Inc.
- 2025
- Oct 8, 2026
- 18
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Abraham Ceesay files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Third Rock Ventures V, L.P. - $34.39M in RAPP purchases and sales in the last 12 months
- Krishnaswamy Yeleswaram - $4.46M in RAPP purchases and sales in the last 12 months
- Cheryl Gault - $1.24M in RAPP purchases and sales in the last 12 months
- David Bredt - $1.14M in RAPP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Abraham Ceesay?
Abraham Ceesay is a corporate insider, tracked as Chief Executive Officer, Director of Rapport Therapeutics, Inc. (RAPP). InsiderAlpha holds 18 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Abraham Ceesay submitted recently?
6 primary Form 4 filings in the last 90 days, covering 1 company.
Has Abraham Ceesay been buying or selling stock?
Recorded transactions: 0 open-market purchases and 44 open-market sales ($8.29M) across all tracked filings.
